Diabetes Therapy
Therapy with propionyl L-carnitine may improve diabetes-associated peripheral arterial disease
Published in Obesity and Diabetes Week, August 14th, 2006
In a recent report, researchers in Italy conducted a study "to investigate the effects of propionyl L-carnitine (PLC) on clinical and functional parameters, and markers of the overall oxidation state in patients with peripheral arterial disease (PAD) associated with noninsulin-dependent diabetes mellitus (NIDDM). Randomised, double-blind, clinical trial, conducted in the Unit of Medical Angiology of the University of Catania."
"Seventy-four patients with NIDDM-associated PAD were treated with PLC (2 g/day) or placebo...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
More Articles from Obesity and Diabetes Week
- Diabetes Pathogenesis
Hepatocytes cocultured with fat cells showed cellular insulin resistance - Diabetes Pathogenesis
High C-reactive protein may play a role in insulin resistance and type 2 diabetes development - Diabetes Therapy
Pioglitazone prevents cardiac remodeling in induced type 2 diabetes mellitus - Diabetic Neuropathy
Aspartoacylase upregulation may contribute to diabetic neuropathy in obesity-induced diabetes - Obesity Epidemiology
Interleukin-6 receptor gene variants associated with BMI and metabolic syndrome factors - Adipose Tissue
Subepicardial adipose tissue thickness was not linked to coronary artery disease severity - More from this issue of Obesity and Diabetes Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
